Loading...
Please wait, while we are loading the content...
Similar Documents
Von Drygalski A, Giermasz A, Castaman G, et al. Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B. Blood Adv. 2019;3(21):3241-3247.
| Content Provider | Scilit |
|---|---|
| Copyright Year | 2020 |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422115/pdf |
| Ending Page | 3668 |
| Page Count | 1 |
| Starting Page | 3668 |
| DOI | 10.1182/bloodadvances.2020002987 |
| Journal | Blood advances |
| Issue Number | 15 |
| Volume Number | 4 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2020-08-11 |
| Access Restriction | Open |
| Subject Keyword | Health Policy and Services Journal: Blood advances (Vol- 125, Issue- 15) |
| Content Type | Text |
| Resource Type | Article |